Thyrogen recombinant thyroid stimulating hormone data

GENZ announced that results of a second Phase III trial of Thyrogen showed that radioiodine scans in patients using Thyrogen were equivalent to those from patients stopping therapy with thyroid hormone, without symptoms of hypothyroidism.

Withdrawal from replacement thyroid hormone

Read the full 403 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE